Advanced Health Intelligence Ltd Announces Implementation of ADS Ratio Change
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”)...
Staff
VitalHub Corp. Announces Results of Annual General Meeting of Shareholders
TORONTO, June 29, 2023 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) today reported a...
Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...
Four Genesis HealthCare-Affiliated Skilled Nursing Facilities Earn 2023 AHCA/NCAL Silver National Quality Award
National award honors long term care providers who demonstrate high-level performance and quality outcomes.KENNETT SQUARE, Pa., June 29, 2023 (GLOBE...
Synchrony’s CareCredit Integration with Nextech Expands Practice and Patient Financial Options
Integration expansion enables streamlined payment options for Nextech clientsTAMPA, Fla., June 29, 2023 (GLOBE NEWSWIRE) -- Nextech, a complete healthcare...
Ardelyx, Inc. Reports Employment Inducement Grants
WALTHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,...
Celularity Announces Presentation at Upcoming 7th International Conference on Orthopedics
Data will be presented from an in vitro study of decellularized-flowable placental connective tissue matrix supporting cellular functions of human...
Zymeworks Appoints New Director
VANCOUVER, British Columbia, June 29, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional...
Accolade Announces Results for Fiscal First Quarter 2024
Accolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) --...
Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer
SAN FRANCISCO, June 29, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Sasha Damouni...
Curia wins 2023 Frost & Sullivan Customer Value Leadership Award
Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative approach and growth strategyALBANY, N.Y.,...
Equip’s Virtual Eating Disorder Treatment Exhibits Exceptional Patient Outcomes, Breaks Barriers to Care
Available nationwide and through most major insurance plans, Equip’s evidence-based treatment is effective among thousands of patientsSAN DIEGO, June 29,...
Privia Health Announces Expansion of and Changes to Board of Directors
Distinguished Healthcare Leader Adam Boehler to Join BoardIncoming CEO Parth Mehrotra to Join BoardWill Sherrill Resigns from BoardARLINGTON, Va,, June...
Evelo Biosciences Announces Reverse Stock Split Effective
– EVLO common stock expected to begin trading on a split-adjusted basis on June 30, 2023 – CAMBRIDGE, Mass., June 29,...
Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment
Submitted NDA for Libervant™ (diazepam) Buccal Film for treatment of seizure clusters in patients between two and five years of...
BioSig Joins Webull Corporate Connect
Webull’s investor community can now access real-time BioSig investor communications and Q&AWestport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig...
Elucent Announces Key Executive Appointments to Chief Executive Officer & Chief Financial Officer
Jason Pesterfield, Veteran Med-Tech Executive and Growth Strategist, Named President, and CEO Kirk G. Jacquay, Seasoned Finance & Operations Leader,...
NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosing
New preclinical data validates that Stealth Editors™ are non-immunogenic, as featured in a poster presentation at the 28th American Peptide...
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
The study was conducted over two days by a team of global key opinion leaders and with participation of executives...
Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004
-- Represents the final step before submission of Investigational New Drug (IND) application to FDA, expected in the second half...